APO RIS 35 (Risedronate Sodium 35 mg)
Pill with imprint APO RIS 35 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Apotex Corp..
Risedronate is used in the treatment of paget's disease; prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO RIS 35
Risedronate Sodium
- Imprint
- APO RIS 35
- Strength
- 35 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-3165
More about risedronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 53 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.